NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Linneo Health

Linneo Health

Private
MadridHealthcare & Life Scienceshttps://linneohealth.com/

Last Round

Corporate Funding

Nov 1, 2024

Total Funding Raised

$25.37M

Company Overview

Linneo Health is a pharmaceutical company that specializes in the research, cultivation, and supply of medicinal cannabis flowers, extracts, and products for pharmaceutical partners.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

medicinal cannabisactive pharmaceutical ingredientsAPIcannabis cultivationEU-GMP certifiedpharma supply chaincontract manufacturingCMOcannabis extractsmedical marijuanapharmaceutical raw materialscannabis researchB2B pharmacannabis processing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Linneo Health Comparables

Compare Linneo Health with similar companies based on industry and business-model similarity.

Linneo Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Brains Bioceutical Corp
88%
Symtomax
83%
Bedrocan
81%

Linneo Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingNov 1, 2024
Corporate FundingJun 1, 2024
Corporate FundingJan 1, 2019
Corporate FundingSep 1, 2018

Key People

Founding team and executive leadership

Don Bellamy

Chief Executive Officer

Executive Team

Gerardo Gorostiza

CFO - Chief Financial and Strategy Officer

Executive Team

Linneo Health Investors

Notable investors and investment history

Linneo Health investors
InvestorRounds
GHO CapitalCorporate Funding
TorrealCorporate Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 13, 2025

    Monthly visitors grew 204% MoM, reaching 2.9K.

  • Jun 1, 2024

    $4.83M round with GHO Capital and Torreal.

Linneo Health Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Linneo Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Linneo Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersMadrid
Employee Range104
Year Founded2018
Last FundingNov 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.